[go: up one dir, main page]

Follow
Amit Mandoli
Amit Mandoli
National Institute of Pharmaceutical Education and Research, Ahmedabad
Verified email at ncmls.ru.nl
Title
Cited by
Cited by
Year
Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity
S Saeed, J Quintin, HHD Kerstens, NA Rao, A Aghajanirefah, F Matarese, ...
science 345 (6204), 1251086, 2014
18252014
The allelic landscape of human blood cell trait variation and links to common complex disease
WJ Astle, H Elding, T Jiang, D Allen, D Ruklisa, AL Mann, D Mead, ...
Cell 167 (5), 1415-1429. e19, 2016
13842016
Genetic drivers of epigenetic and transcriptional variation in human immune cells
L Chen, B Ge, FP Casale, L Vasquez, T Kwan, D Garrido-Martín, S Watt, ...
Cell 167 (5), 1398-1414. e24, 2016
7692016
Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics
A Chamoli, AS Gosavi, UP Shirwadkar, KV Wangdale, SK Behera, ...
Oral oncology 121, 105451, 2021
6422021
Azine-Based Receptor for Recognition of Hg2+ Ion: Crystallographic Evidence and Imaging Application in Live Cells
M Suresh, AK Mandal, S Saha, E Suresh, A Mandoli, R Di Liddo, ...
Organic Letters 12 (23), 5406-5409, 2010
1652010
Physiological characterization and stress-induced metabolic responses of Dunaliella salina isolated from salt pan
A Mishra, A Mandoli, B Jha
Journal of industrial microbiology and biotechnology 35 (10), 1093, 2008
1412008
MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia
KHM Prange, A Mandoli, T Kuznetsova, SY Wang, AM Sotoca, ...
Oncogene 36 (23), 3346-3356, 2017
1312017
ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia
JHA Martens, A Mandoli, F Simmer, BJ Wierenga, S Saeed, AA Singh, ...
Blood, The Journal of the American Society of Hematology 120 (19), 4038-4048, 2012
1202012
CBFB–MYH11/RUNX1 together with a compendium of hematopoietic regulators, chromatin modifiers and basal transcription factors occupies self-renewal genes in inv (16) acute …
A Mandoli, AA Singh, P Jansen, ATJ Wierenga, H Riahi, G Franci, ...
Leukemia 28 (4), 770-778, 2014
942014
E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer
K Teo, L Gómez-Cuadrado, M Tenhagen, A Byron, M Rätze, ...
Scientific reports 8 (1), 15454, 2018
762018
The hematopoietic transcription factors RUNX1 and ERG prevent AML1-ETO oncogene overexpression and onset of the apoptosis program in t (8; 21) AMLs
A Mandoli, AA Singh, KHM Prange, E Tijchon, M Oerlemans, R Dirks, ...
Cell reports 17 (8), 2087-2100, 2016
762016
Joosten
S Saeed, J Quintin, HHD Kerstens, NA Rao, A Aghajanirefah, F Matarese, ...
LAB, Wijmenga, C., Martens, JHA, Xavier, RJ, Logie, C., Netea, MG …, 2014
722014
Glucocorticoid receptor and nuclear factor kappa-b affect three-dimensional chromatin organization
T Kuznetsova, SY Wang, NA Rao, A Mandoli, JHA Martens, N Rother, ...
Genome biology 16 (1), 264, 2015
672015
Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent CCNE1 and IGF2 enhancer hijacking in primary gastric adenocarcinoma
WF Ooi, AM Nargund, KJ Lim, S Zhang, M Xing, A Mandoli, JQ Lim, ...
Gut 69 (6), 1039-1052, 2020
592020
The oncofusion protein FUS–ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t (16; 21) acute myeloid leukemia
AM Sotoca, KHM Prange, B Reijnders, A Mandoli, LN Nguyen, ...
Oncogene 35 (15), 1965-1976, 2016
592016
Increased H3K9 methylation and impaired expression of Protocadherins are associated with the cognitive dysfunctions of the Kleefstra syndrome
G Iacono, A Dubos, H Méziane, M Benevento, E Habibi, A Mandoli, F Riet, ...
Nucleic Acids Research 46 (10), 4950-4965, 2018
542018
MEIS2 is an oncogenic partner in AML1-ETO-positive AML
NM Vegi, J Klappacher, F Oswald, MA Mulaw, A Mandoli, VN Thiel, ...
Cell reports 16 (2), 498-507, 2016
542016
Chromatin-based classification of genetically heterogeneous AMLs into two distinct subtypes with diverse stemness phenotypes
G Yi, ATJ Wierenga, F Petraglia, P Narang, EM Janssen-Megens, ...
Cell reports 26 (4), 1059-1069. e6, 2019
472019
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392
F De Bellis, V Carafa, M Conte, D Rotili, F Petraglia, F Matarese, ...
Cancer research 74 (8), 2328-2339, 2014
362014
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer
M Xing, WF Ooi, J Tan, A Qamra, PH Lee, Z Li, C Xu, N Padmanabhan, ...
The Journal of clinical investigation 130 (6), 3005-3020, 2020
322020
The system can't perform the operation now. Try again later.
Articles 1–20